About Xenagos Bio
Xenagos Bio is a private company based in Philadelphia, Pennsylvania, incorporated in 2025 in Delaware. It has reported $2,520,000 raised in one offering on Form D since May 2026. Its chief executive is Michael McElhaugh.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | May 15, 2026 | $2,520,000fully sold | 23 | $109K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Xenagos Bio's Form D filed May 15, 2026.
